Table 1.
List of primer used during the study. Primer sequences are given in 5′ to 3′ direction.
| Factor | Primer Name | Sequence 5’–3’ |
|---|---|---|
| 18S rRNA | 18s-F | GGAGCCTGCGGCTTAATTT |
| 18s-R | CAACTAAGAACGGCCATGCA | |
| Annexin A1; ANXA1 | ANXA1-F | GCCAAAGACATAACCTCAGACACAT |
| ANXA1-R | GAATCAGCCAAGTCTTCATTCACA | |
| Annexin A2; ANXA2 | ANXA2-F | GGTACAAGAGTTACAGCCCTTATGACA |
| ANXA2-R | CATGGAGTCATACAGCCGATCA | |
| BCL2 Associated X, Apoptosis Regulator; BAX | Bax-F | GTCAGCTGCCACTCGGAAA |
| Bax-R | AGTAACATGGAGCTGCAGAGGAT | |
| B-cell lymphoma 2; BCL2 | Bcl2-F | TCAGAGACAGCCAGGAGAAATCA |
| Bcl2-R | CCTGTGGATGACTGAGTACCTGAA | |
| Caspase 3; CASP3 | Casp3-F | CTCCAACATCGACTGTGAGAAGTT |
| Casp3-R | GCGCCAGCTCCAGCAA | |
| CD44 | CD44-F | ACCCTCCCCTCATTCACCAT |
| CD44-R | GTTGTACTACTAGGAGTTGCCTGGATT | |
| Extracellular signal-regulated kinases 1; ERK1 | ERK1-F | ACCTGCGACCTTAAGATTTGTGA |
| ERK1-R | AGCCACATACTCCGTCAGGAA | |
| Extracellular signal-regulated kinases 2; ERK2 | ERK2-F | TTCCAACCTGCTGCTCAACA |
| ERK2-R | TCTGTCAGGAACCCTGTGTGAT | |
| Focal adhesion kinase 1 (Protein-tyrosine kinase 2); pan-FAK1 | FAK1-F | TGTGGGTAAACCAGATCCTGC |
| FAK1-R | CTGAAGCTTGACACCCTCGT | |
| Intercellular adhesion molecule 1; ICAM1 | ICAM1-F | CGGCTGACGTGTGCAGTAAT |
| ICAM1-R | CTTCTGAGACCTCTGGCTTCGT | |
| Mitogen-activated protein kinase 8 (MAPK8) (JNK1-a2); MAPK8/JNK1 | JNK1-F | TCTCCTTTAGGTGCAGCAGTG |
| JNK1-R | CAGAGGCCAAAGTCGGATCT | |
| NF-kappa-B transcription complex P105/P50; NFKB1 | NFkB1-F | CTTAGGAGGGAGAGCCCAC |
| NFkB1-R | TGAAACATTTGTTCAGGCCTTC | |
| NF-kappa-B transcription complex P100/P52; NFKB2 | NFkB2-F | GTACAAAGATACGCGGACCC |
| NFkB2-R | CCAGACCTGGGTTGTAGCA | |
| NF-kappa-B transcription complex P65; NFKB P65 | NFkB P65-F | CGCTTCTTCACACACTGGATTC |
| NFkB P65-R | ACTGCCGGGATGGCTTCT | |
| NF-kappa-B essential modulator (NEMO); IKBKG | IkBKG-F | AACTGGGACTTTCTCGGAGC |
| IkBKG-R | GGCAAGGGCTGTCAGCAG | |
| NF-kappa-B inhibitor alpha; NFKBIA | NFkBIa-F | AATGCTCAGGAGCCCTGTAAT |
| NFkBIa-R | CTGTTGACATCAGCCCCACA | |
| NF-kappa-B inhibitor beta; NFKBIB | NFkBIb-F | CCCGGAGGACCTGGGTT |
| NFkBIb-R | GCAGTGCCGTGTCCCC | |
| NF-kappa-B inhibitor epsilon; NFKBIE | NFkBIe-F | TGGGCATCTCATCCACTCTG |
| NFkBIe-R | ACAAGGGATTCCTCAGTCAGGT | |
| Protein kinase C alpha type; PRKCA | PRKCA-F | TGGGTCACTGCTCTATGGACTTATC |
| PRKCA-R | CGCCCCCTCTTCTCAGTGT | |
| TATA-box binding protein; TBP | TBP-F | GTGACCCAGCATCACTGTTTC |
| TBP-R | GCAAACCAGAAACCCTTGCG | |
| Raf-1 Proto-Oncogene, Serine/Threonine Kinase; Raf1 | Raf1-F | GGGAGCTTGGAAGACGATCAG |
| Raf1-R | ACACGGATAGTGTTGCTTGTC | |
| Osteopontin (OPN); SPP1 | SPP1-F | CGAGGTGATAGTGTGGTTTATGGA |
| SPP1-R | CGTCTGTAGCATCAGGGTACTG | |
| Vascular cell adhesion protein 1; VCAM1 | VCAM1-F | CATGGAATTCGAACCCAAACA |
| VCAM1-R | GGCTGACCAAGACGGTTGTATC |